BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 18073065)

  • 21. Occult hepatitis B virus infection is associated with the development of hepatocellular carcinoma in chronic hepatitis C patients.
    Squadrito G; Pollicino T; Cacciola I; Caccamo G; Villari D; La Masa T; Restuccia T; Cucinotta E; Scisca C; Magazzu D; Raimondo G
    Cancer; 2006 Mar; 106(6):1326-30. PubMed ID: 16453330
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HBV DNA integration and HBV-transcript expression in non-B, non-C hepatocellular carcinoma in Japan.
    Tamori A; Nishiguchi S; Kubo S; Narimatsu T; Habu D; Takeda T; Hirohashi K; Shiomi S
    J Med Virol; 2003 Dec; 71(4):492-8. PubMed ID: 14556260
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analysis of risk factors for hepatocellular carcinoma that is negative for hepatitis B surface antigen (HBsAg).
    Shimada S; Aizawa R; Abe H; Suto S; Miyakawa Y; Aizawa Y
    Intern Med; 2003 May; 42(5):389-93. PubMed ID: 12793707
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical features of patients with HCC who are negative for both HBV and HCV markers.
    Watabe H; Shiratori Y; Tateishi R; Fujishima T; Akamatsu M; Koike Y; Obi S; Hamamura K; Sato S; Teratani T; Shiina S; Omata M
    Hepatogastroenterology; 2003; 50(54):2157-60. PubMed ID: 14696486
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relationship between sustained elevation of serum alanine aminotransferase and progression from cirrhosis to hepatocellular carcinoma: comparison in patients with hepatitis B virus- and hepatitis C virus-associated cirrhosis.
    Sato A; Kato Y; Nakata K; Nakao K; Daikoku M; Ishii N; Matsumoto T; Iseki K; Mazume H; Nagataki S
    J Gastroenterol Hepatol; 1996 Oct; 11(10):944-8. PubMed ID: 8912132
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High prevalence of hepatitis B virus infection and inferior vena cava obstruction among patients with liver cirrhosis or hepatocellular carcinoma in Nepal.
    Shrestha SM; Shrestha S; Shrestha A; Tsuda F; Endo K; Takahashi M; Okamoto H
    J Gastroenterol Hepatol; 2007 Nov; 22(11):1921-8. PubMed ID: 17914971
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Different expression of hepatitis B surface antigen between hepatocellular carcinoma and its surrounding liver tissue, studied using a tissue microarray.
    Wang Y; Wu MC; Sham JS; Tai LS; Fang Y; Wu WQ; Xie D; Guan XY
    J Pathol; 2002 Aug; 197(5):610-6. PubMed ID: 12210080
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hepatitis C virus in chronic liver disease and hepatocellular carcinoma in Taiwan.
    Chen DS
    Princess Takamatsu Symp; 1995; 25():27-32. PubMed ID: 8875606
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lack of correlation between serum anti-HBcore detectability and hepatocellular carcinoma in patients with HCV-related cirrhosis.
    Stroffolini T; Almasio PL; Persico M; Bollani S; Benvegnù L; Di Costanzo G; Pastore G; Aghemo A; Stornaiuolo G; Mangia A; Andreone P; Stanzione M; Mazzella G; Saracco G; Del Poggio P; Bruno S;
    Am J Gastroenterol; 2008 Aug; 103(8):1966-72. PubMed ID: 18637087
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Alpha-fetoprotein as a tumor marker in hepatocellular carcinoma: investigations in south Indian subjects with hepatotropic virus and aflatoxin etiologies.
    Murugavel KG; Mathews S; Jayanthi V; Shankar EM; Hari R; Surendran R; Vengatesan A; Raghuram K; Rajasambandam P; Murali A; Srinivas U; Palaniswamy KR; Pugazhendhi T; Thyagarajan SP
    Int J Infect Dis; 2008 Nov; 12(6):e71-6. PubMed ID: 18658001
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular and serological aspects of HBsAg-negative hepatitis B virus infections in North America.
    Hsia CC; Scudamore CH; Di Bisceglie AM; Tabor E
    J Med Virol; 2003 May; 70(1):20-6. PubMed ID: 12629639
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lower serum viral loads in young patients with hepatitis-B-virus-related hepatocellular carcinoma.
    Tsai FC; Liu CJ; Chen CL; Chen PJ; Lai MY; Kao JH; Chen DS
    J Viral Hepat; 2007 Mar; 14(3):153-60. PubMed ID: 17305880
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of c-kit protooncogen in hepatitis B virus-induced chronic hepatitis, cirrhosis and hepatocellular carcinoma: has it a diagnostic role?
    Kara B; Doran F; Kara IO; Akkiz H; Sandikci M
    Int J Clin Pract; 2008 Aug; 62(8):1206-11. PubMed ID: 18284441
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Utility of alpha-fetoprotein (AFP) in the screening of patients with virus-related chronic liver disease: does different viral etiology influence AFP levels in HCC? A study in 350 western patients.
    Cedrone A; Covino M; Caturelli E; Pompili M; Lorenzelli G; Villani MR; Valle D; Sperandeo M; Rapaccini GL; Gasbarrini G
    Hepatogastroenterology; 2000; 47(36):1654-8. PubMed ID: 11149026
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Hepatitis B virus DNA detection by means of polymerase chain reaction in patients with chronic hepatitis and hepatocellular carcinoma].
    Song Y; Pan W; Fan Z; Du P; Qi Z
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1997 Sep; 11(3):220-2. PubMed ID: 15617333
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Previous or occult hepatitis B virus infection in hepatitis B surface antigen-negative and anti-hepatitis C-negative patients with hepatocellular carcinoma.
    Ohba K; Kubo S; Tamori A; Hirohashi K; Tanaka H; Shuto T; Nishiguchi S; Kinoshita H
    Surg Today; 2004; 34(10):842-8. PubMed ID: 15449154
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The discrepancy of HBsAg titre and HBV DNA in patients with chronic hepatitis B, HBV-related liver cirrhosis and hepatocellular carcinoma].
    Pei YZ; Han T; Ma XY; Li Y; Xing J; Song ZL
    Zhonghua Gan Zang Bing Za Zhi; 2011 Oct; 19(10):743-6. PubMed ID: 22409845
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression profile of nine novel genes differentially expressed in hepatitis B virus-associated hepatocellular carcinomas.
    Kim MY; Park E; Park JH; Park DH; Moon WS; Cho BH; Shin HS; Kim DG
    Oncogene; 2001 Jul; 20(33):4568-75. PubMed ID: 11494152
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hepatitis C and B virus infections in hepatocellular carcinoma. Analysis of direct detection of viral genome in paraffin embedded tissues.
    Edamoto Y; Tani M; Kurata T; Abe K
    Cancer; 1996 May; 77(9):1787-91. PubMed ID: 8646675
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rate of incidence of hepatocellular carcinoma in patients with compensated viral cirrhosis.
    Chiaramonte M; Stroffolini T; Vian A; Stazi MA; Floreani A; Lorenzoni U; Lobello S; Farinati F; Naccarato R
    Cancer; 1999 May; 85(10):2132-7. PubMed ID: 10326690
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.